A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT00963768 · COMPLETED
Trial details
- NCT number
- NCT00963768
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.